Varghese N, Knight R, Gallagher L, Ti L Treatment of hepatitis C virus infection in marginalized populations Am J Nurs, 2020. PubMed

Salleh NAM, Van Draanen J, Nosova E, Barrios R, Milloy MJ, Richardson L Material security and adherence to antiretroviral therapy (ART) among HIV-positive people who use illicit drugs AIDS, 2020. PubMed

Socías ME, Dong H, Wood E, Brar R, Richardson L, Hayashi K, Kerr T, Milloy MJ Trajectories of retention in opioid agonist therapy in a Canadian setting Int J Drug Policy, 2020. PubMed

Blumenkrans E, Socías ME, Richardson L, Kerr T, Shoveller J, Montaner J, Milloy MJ Longitudinal factors associated with used syringe lending among HIV-positive antiretroviral therapy-naïve people who inject drugs in a Canadian setting AIDS Behav, 2020. PubMed

Wilson T, Brar R, Sutherland C, Nolan S Use of a primary care and pharmacy-based model for the delivery of injectable opioid agonist treatment for severe opioid use disorder: a case report CMAJ, 2020. Link

Lake S, Kerr T, Buxton J, Walsh Z, Marshall BDL, Wood E, Milloy MJ Does cannabis use modify the effect of post-traumatic stress disorder on severe depression and suicidal ideation? Evidence from a population-based cross-sectional study of Canadians J Psychopharmacol, 2020. PubMed

Schwartz C, Fast D, Knight R Poppers, queer sex and a Canadian crackdown: examining the experiences of alkyl nitrite use among young sexual minority men Int J Drug Policy, 2020. PubMed

Danilewitz M, McLean M High-dose buprenorphine for treatment of high potency opioid use disorder Drug Alcohol Rev, 2020. PubMed

Collins AB, Boyd J, Hayashi K, Cooper HLF, Goldenberg S, McNeil R Women's utilization of housing-based overdose prevention sites in Vancouver, Canada: an ethnographic study Int J Drug Policy, 2020. PubMed

McAdam M, Brar R, Young S Initiation of injectable opioid agonist treatment in hospital: a case report Drug Alcohol Rev, 2020. PubMed